Literature DB >> 10028527

Parasite killing in murine malaria does not require nitric oxide production.

N Favre1, B Ryffel, W Rudin.   

Abstract

Nitric oxide (NO) production has been suggested to play a role as effector molecule in the control of the malarial infections. However, the roles of this molecule are debated. To assess whether blood-stage parasite killing is NO dependent, we investigated the course of blood-stage Plasmodium chabaudi chabaudi (Pcc) infections in inducible nictric oxide synthase (iNOS)-deficient mice. Parasitaemia, haematological alterations, and survival were not affected by the lack of iNOS. To exclude a role of NO produced by other NOS, controls included NO suppression by oral administration of aminoguanidine (AG), a NOS inhibitor. As in iNOS-deficient mice, no difference in the parasitaemia course, survival and haematological values was observed after AG treatment. Our results indicate that NO production is not required for protection against malaria in our murine experimental model. However, C57BL/6 mice treated with AG lost their resistance to Pcc infections, suggesting that the requirement for NO production for parasite killing in murine blood-stage malaria might be strain dependent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028527     DOI: 10.1017/s0031182098003618

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  9 in total

1.  Host-parasite interactions revealed by Plasmodium falciparum metabolomics.

Authors:  Kellen L Olszewski; Joanne M Morrisey; Daniel Wilinski; James M Burns; Akhil B Vaidya; Joshua D Rabinowitz; Manuel Llinás
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

2.  Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Authors:  Michael Hawkes; Robert Opika Opoka; Sophie Namasopo; Christopher Miller; Andrea L Conroy; Lena Serghides; Hani Kim; Nisha Thampi; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Med Hypotheses       Date:  2011-07-13       Impact factor: 1.538

3.  Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections.

Authors:  S M Potter; A J Mitchell; W B Cowden; L A Sanni; M Dinauer; J B de Haan; N H Hunt
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Plasmodium berghei resists killing by reactive oxygen species.

Authors:  Peter Sobolewski; Irene Gramaglia; John A Frangos; Marcos Intaglietta; Henri van der Heyde
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Suppression of Plasmodium chabaudi parasitemia is independent of the action of reactive oxygen intermediates and/or nitric oxide.

Authors:  Brad M Gillman; Joan Batchelder; Patrick Flaherty; William P Weidanz
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice.

Authors:  Michael Saeftel; Andreas Krueger; Sandra Arriens; Volker Heussler; Paul Racz; Bernhard Fleischer; Frank Brombacher; Achim Hoerauf
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 7.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Chickens treated with a nitric oxide inhibitor became more resistant to Plasmodium gallinaceum infection due to reduced anemia, thrombocytopenia and inflammation.

Authors:  Barbarella Matos de Macchi; Farlen José Bebber Miranda; Fernanda Silva de Souza; Eulógio Carlos Queiroz de Carvalho; Antônio Peixoto Albernaz; José Luiz Martins do Nascimento; Renato Augusto DaMatta
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

Review 9.  Oxidative stress in malaria.

Authors:  Sandro Percário; Danilo R Moreira; Bruno A Q Gomes; Michelli E S Ferreira; Ana Carolina M Gonçalves; Paula S O C Laurindo; Thyago C Vilhena; Maria F Dolabela; Michael D Green
Journal:  Int J Mol Sci       Date:  2012-12-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.